These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 31575425

  • 1. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Löffler AI, Pan JA, Balfour PC, Shaw PW, Yang Y, Nasir M, Auger DA, Epstein FH, Kramer CM, Gan LM, Salerno M.
    Am J Cardiol; 2019 Nov 15; 124(10):1584-1589. PubMed ID: 31575425
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P, Cheng ASH, Singh A, Khan JN, Gulsin GS, Patel P, Gupta P, Arnold JR, Squire IB, Ng LL, McCann GP.
    JACC Cardiovasc Imaging; 2019 Nov 15; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Arnold JR, Kanagala P, Budgeon CA, Jerosch-Herold M, Gulsin GS, Singh A, Khan JN, Chan DCS, Squire IB, Ng LL, McCann GP.
    JACC Cardiovasc Imaging; 2022 Jun 15; 15(6):1001-1011. PubMed ID: 35033490
    [Abstract] [Full Text] [Related]

  • 7. Myocardial contrast echocardiography evaluation of coronary microvascular dysfunction to Predict MACEs in patients with heart failure with preserved ejection fraction follow-up.
    Chen F, Weng W, Yang D, Wang X, Zhou Y.
    BMC Cardiovasc Disord; 2024 Sep 18; 24(1):496. PubMed ID: 39289634
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP, von Roeder M, Latuscynski K, Oberueck C, Blazek S, Fengler K, Besler C, Sandri M, Lücke C, Gutberlet M, Linke A, Schuler G, Lurz P.
    J Am Coll Cardiol; 2016 Apr 19; 67(15):1815-1825. PubMed ID: 27081022
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of elevated left ventricular end diastolic pressure in patients with preserved ejection fraction using cardiac magnetic resonance.
    Gao C, Tao Y, Pan J, Shen C, Zhang J, Xia Z, Wan Q, Wu H, Gao Y, Shen H, Lu Z, Wei M.
    Eur Radiol; 2019 May 19; 29(5):2360-2368. PubMed ID: 30631923
    [Abstract] [Full Text] [Related]

  • 11. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ, Tschöpe C.
    J Am Coll Cardiol; 2013 Jul 23; 62(4):263-71. PubMed ID: 23684677
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interdependence between myocardial deformation and perfusion in patients with T2DM and HFpEF: a feature-tracking and stress perfusion CMR study.
    Li XN, Liu YT, Kang S, Qu Yang DZ, Xiao HY, Ma WK, Shen CX, Pan JW.
    Cardiovasc Diabetol; 2024 Aug 16; 23(1):303. PubMed ID: 39152461
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF, Hussain S, Mirzoyev SA, Edwards WD, Maleszewski JJ, Redfield MM.
    Circulation; 2015 Feb 10; 131(6):550-9. PubMed ID: 25552356
    [Abstract] [Full Text] [Related]

  • 17. Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience.
    Schwarz K, Ahearn T, Srinivasan J, Neil CJ, Scally C, Rudd A, Jagpal B, Frenneaux MP, Pislaru C, Horowitz JD, Dawson DK.
    J Am Soc Echocardiogr; 2017 Aug 10; 30(8):745-755. PubMed ID: 28599831
    [Abstract] [Full Text] [Related]

  • 18. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY, Lin LY, Tseng YH, Chang CC, Wu CK, Lin JL, Tseng WY.
    JACC Cardiovasc Imaging; 2014 Oct 10; 7(10):991-7. PubMed ID: 25240451
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.